A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : CCL2

Search Conditions:
Search Keyword : CCL2
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: CCL2
Appearance Frequency: 386 time(s)
Long forms: 33

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
CC chemokine ligand 2
(229 times)
Allergy and Immunology
(45 times)
CCR2 (32 times)
TNF-alpha (22 times)
IL (18 times)
2002 The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice.
C-C motif ligand 2
(82 times)
Neurology
(14 times)
IL (11 times)
CCR2 (9 times)
TNF-alpha (9 times)
2006 Regulation of chemokine production in response to pro-inflammatory cytokines in first trimester decidual cells.
chemokine CC motif ligand 2
(21 times)
Molecular Biology
(5 times)
HAND (3 times)
BCa (2 times)
CCR2 (2 times)
2006 Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain.
C-C ligand 2
(12 times)
Allergy and Immunology
(2 times)
CCR2 (4 times)
CNS (2 times)
IL-1beta (2 times)
2001 Cutting edge: Differential regulation of chemoattractant receptor-induced degranulation and chemokine production by receptor phosphorylation.
CC chemokine receptor-2 ligand
(4 times)
Pulmonary Medicine
(1 time)
alpha-SMA (1 time)
CAFs (1 time)
CCR2 (1 time)
2004 Platelet-activating factor-induced chemokine gene expression requires NF-kappaB activation and Ca2+/calcineurin signaling pathways. Inhibition by receptor phosphorylation and beta-arrestin recruitment.
CC chemokine ligand 2/monocyte chemoattractant protein-1
(3 times)
Chemistry
(1 time)
CTGF (1 time)
IL (1 time)
NE (1 time)
2004 Increased norepinephrine production associated with burn injuries results in CCL2 production and type 2 T cell generation.
chemoattractant chemokine ligand 2
(3 times)
Neoplasms
(1 time)
AFRS (1 time)
B-ALL (1 time)
BM (1 time)
2012 Increased presence of dendritic cells and dendritic cell chemokines in the sinus mucosa of chronic rhinosinusitis with nasal polyps and allergic fungal rhinosinusitis.
chemokine CC ligand 2
(3 times)
Molecular Biology
(1 time)
CHI (1 time)
CSF (1 time)
NO (1 time)
2009 Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice.
chemotactic cytokine ligand 2
(3 times)
Molecular Biology
(1 time)
CRLs (1 time)
EMT (1 time)
MAPK (1 time)
2009 Chemokines and pain mechanisms.
10  CCL2-NKT cells
(2 times)
Traumatology
(1 time)
HSV-1 (1 time)
IL (1 time)
NKT (1 time)
2005 Role of natural killer T (NKT) cells lacking interleukin (IL)-4 producing abilities on the CC-chemokine ligand 2-associated herpes simplex virus type 1 infection in human severe combined immunodeficiency (SCID) mouse chimeras.
11  Coprinopsis cinerea lectin 2
(2 times)
Medicine
(1 time)
WT (1 time)
2015 Disruption of the C. elegans Intestinal Brush Border by the Fungal Lectin CCL2 Phenocopies Dietary Lectin Toxicity in Mammals.
12  C-C chemokine motif ligand 2
(1 time)
Biochemistry
(1 time)
FPRL1 (1 time)
HUVECs (1 time)
SAA (1 time)
2009 Activation of formyl peptide receptor like-1 by serum amyloid A induces CCL2 production in human umbilical vein endothelial cells.
13  C-C class chemokine-2
(1 time)
Brain
(1 time)
CB2R (2 times)
DRG (1 time)
KO (1 time)
2021 Peripherally administered cannabinoid receptor 2 (CB2R) agonists lose anti-allodynic effects in TRPV1 knockout mice, while intrathecal administration leads to anti-allodynia and reduced GFAP, CCL2 and TRPV1 expression in the dorsal spinal cord and DRG.
14  candidate contaminant list # 2
(1 time)
Environmental Health
(1 time)
HSDM (1 time)
RSSCTs (1 time)
USEPA (1 time)
2007 Vanadium removal by metal (hydr)oxide adsorbents.
15  CC chemokine family ligand 2
(1 time)
Neurology
(1 time)
CD163 (1 time)
HAND (1 time)
Nef (1 time)
2019 TGFbetaRI antagonist inhibits HIV-1 Nef-induced CC chemokine family ligand 2 (CCL2) in the brain and prevents spatial learning impairment.
16  CC receptor ligand 2
(1 time)
Science
(1 time)
--- 2014 Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis.
17  CC-cytokine ligand2
(1 time)
Genetics, Medical
(1 time)
AMD (1 time)
AP (1 time)
CCL2-2518 (1 time)
2017 Joint association of complement component 3 and CC-cytokine ligand2 (CCL2) or complement component 3 and CFH polymorphisms in age-related macular degeneration.
18  CCL chemokine 2
(1 time)
Gastroenterology
(1 time)
CD (1 time)
CXCL1 (1 time)
IL1B (1 time)
2008 Ex vivo simulation of IgG Fc and T-cell receptor functions: an application to inflammatory bowel disease.
19  CCL2 to creatinine
(1 time)
Internal Medicine
(1 time)
BKV (1 time)
2019 Urinary levels of CCL2 and CXCL10 chemokines as potential biomarkers of ongoing pathological processes in kidney allograft: an association with BK virus nephropathy.
20  CCL2-B16 cells
(1 time)
Allergy and Immunology
(1 time)
--- 2007 Recombined CC chemokine ligand 2 into B16 cells induces production of Th2-dominant [correction of dominanted] cytokines and inhibits melanoma metastasis.
21  CCL2SMKO
(1 time)
Pharmacology
(1 time)
IL-6 (2 times)
TLR4 (2 times)
CXCL1 (1 time)
2022 Skeletal Muscle Myofibers Directly Contribute to LPS-Induced Systemic Inflammatory Tone.
22  CCR2 and its ligand
(1 time)
Cardiology
(1 time)
CCR (1 time)
CHF (1 time)
2007 A novel activator of C-C chemokine, FROUNT, is expressed with C-C chemokine receptor 2 and its ligand in failing human heart.
23  CCR2 and its ligand MCP-1
(1 time)
Fibrosis
(1 time)
CX3CL1 (1 time)
DC (1 time)
HSC (1 time)
2012 Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo.
24  CCR2 ligands MCP-1
(1 time)
Biochemistry
(1 time)
ESI-FTICR (1 time)
GAG (1 time)
2006 Heterodimerization of CCR2 chemokines and regulation by glycosaminoglycan binding.
25  CCR2-ligand
(1 time)
Natural Science Disciplines
(1 time)
PB (1 time)
PLN (1 time)
T1D (1 time)
2017 Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression.
26  chemical chemokines 2
(1 time)
Chemistry
(1 time)
CD68 (1 time)
HIF-1 (1 time)
IHC (1 time)
2016 Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma.
27  chemoattractant ligand 2
(1 time)
Medicine
(1 time)
I/R (1 time)
IA (1 time)
IL (1 time)
2014 Rho-kinase activation in leukocytes plays a pivotal role in myocardial ischemia/reperfusion injury.
28  chemokine CCL2
(1 time)
Cell Biology
(1 time)
ERK (1 time)
IL-1beta (1 time)
JNK (1 time)
2019 P2Y14 receptor is functionally expressed in satellite glial cells and mediates interleukin-1beta and chemokine CCL2 secretion.
29  chemokines chemokine ligand 2 (C-C motif)
(1 time)
Neurology
(1 time)
ACC (1 time)
HC (1 time)
IR (1 time)
2011 Spinal cord injuries induce changes in CB1 cannabinoid receptor and C-C chemokine expression in brain areas underlying circuitry of chronic pain conditions.
30  chemotactic-C-C-motif-chemokine-ligand-2
(1 time)
Antioxidants
(1 time)
DFAT (1 time)
FASN (1 time)
HS (1 time)
2021 Antioxidant Resveratrol Increases Lipolytic and Reduces Lipogenic Gene Expression under In Vitro Heat Stress Conditions in Dedifferentiated Adipocyte-Derived Progeny Cells from Dairy Cows.
31  coli, BM-Macs also required PRAT4A-independent TLR4/MD-2 for production of MCP-1
(1 time)
Allergy and Immunology
(1 time)
BM-Macs (1 time)
pMacs (1 time)
PRAT4A (1 time)
2011 Intracellular TLR4/MD-2 in macrophages senses Gram-negative bacteria and induces a unique set of LPS-dependent genes.
32  concentration of chemokine ligand 2
(1 time)
Urology
(1 time)
CTL (1 time)
EVI (1 time)
MCP-1 (1 time)
2014 The phytotherapeutic agent, eviprostat, suppresses stromal proliferation and inflammation even after establishment of nonbacterial prostatitis in the rat prostate.
33  cysteine-cysteine chemokine ligand 2
(1 time)
Medicine
(1 time)
MCP-1 (1 time)
PAD (1 time)
2011 Association between plasma monocyte chemoattractant protein-1 levels and the extent of atherosclerotic peripheral artery disease.